Screening for breast cancer and mortality reduction among women 40–49 years of age

The recent withdrawal of screening support for women ages 40–49 years is not scientifically supported. The subgroup analyses that have been used severely compromise the statistical power of the trials. None of the trials has the statistical power to be able to provide clear proof of benefit for scre...

Ausführliche Beschreibung